Identification of several plasma proteins whose levels in colorectal cancer patients differ depending on outcome.

Holm, Matilda; Joenväärä, Sakari; Saraswat, Mayank; Mustonen, Harri; Tohmola, Tiialotta; Ristimäki, Ari; Renkonen, Risto; Haglund, Caj

Holm, Matilda; Joenväärä, Sakari; Saraswat, Mayank; Mustonen, Harri; Tohmola, Tiialotta; Ristimäki, Ari; Renkonen, Risto; Haglund, Caj.

Afiliação

Holm M; Department of Surgery Faculty of Medicine University of Helsinki and Helsinki University Hospital Helsinki Finland.
Joenväärä S; Department of Pathology Faculty of Medicine University of Helsinki and Helsinki University Hospital Helsinki Finland.
Saraswat M; Translational Cancer Medicine Research Program Faculty of Medicine University of Helsinki Helsinki Finland.
Mustonen H; Applied Tumor Genomics Research Program Faculty of Medicine University of Helsinki Helsinki Finland.
Tohmola T; Transplantation Laboratory Haartman Institute University of Helsinki Helsinki Finland.
Ristimäki A; HUSLAB Helsinki University Hospital Helsinki Finland.
Renkonen R; Transplantation Laboratory Haartman Institute University of Helsinki Helsinki Finland.
Haglund C; HUSLAB Helsinki University Hospital Helsinki Finland.

FASEB Bioadv ; 1(12): 723-730, 2019 Dec.

Article em En | MEDLINE | ID: mdl-32123817

Palavras-chave

mass spectrometry; outcome; plasma proteome; proteomics; stage

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies Idioma: En Revista: FASEB Bioadv Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google